T1 Condition 971 978 patient
T2 Condition 1292 1307 advanced cancer
T4 Condition 249 255 cancer
T5 Biomarker 574 595 Di Bella multitherapy
T6 Condition 302 308 cancer
T7 Protein 552 557 drugs
T8 Condition 1278 1285 patient
T9 Condition 1019 1027 patients
T10 Biomarker 627 659 Cyclophosphamide and hydroxyurea
T11 Condition 333 340 patient
T12 Biomarker 529 537 retinoid
T13 Condition 971 979 patients
T14 Disease 792 800 toxicity
T15 Condition 1087 1093 cancer
T16 Condition 1138 1145 patient
T17 Condition 926 934 patients
T18 Condition 1062 1070 patients
T19 Condition 1019 1026 patient
T20 Biomarker 513 523 octreotide
T21 Biomarker 55 76 Di Bella multitherapy
T23 Condition 885 892 patient
T24 Condition 84 94 antitumour
T25 Protein 497 509 somatostatin
T26 Biomarker 475 488 bromocriptine
T27 Condition 926 933 patient
T28 Condition 1062 1069 patient
T29 Biomarker 464 473 Melatonin
T30 Condition 333 341 patients
T31 Condition 1278 1286 patients
T32 Condition 347 362 advanced cancer
T33 Condition 1040 1046 cancer
T34 Condition 1138 1146 patients
T35 Condition 611 619 patients
T36 Condition 611 618 patient
T37 Biomarker 1220 1241 Di Bella multitherapy
